Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C1q anticorps

Cet anticorps anti-C1q Polyclonal Chèvre (ABIN636141) détecte spécifiquement C1q. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN636141
1.159,18 €
Plus frais de livraison 40,00 € et TVA
1 mg
Destination: France
Envoi sous 13 à 17 jours ouvrables

Aperçu rapide pour C1q anticorps (ABIN636141)

Antigène

Voir toutes C1q Anticorps
C1q (Complement Fragment C1q (C1q))

Reactivité

  • 29
  • 15
  • 2
Humain

Hôte

  • 15
  • 15
  • 5
  • 4
  • 4
  • 1
Chèvre

Clonalité

  • 22
  • 21
Polyclonal

Conjugué

  • 24
  • 10
  • 7
  • 1
  • 1
  • 1
Cet anticorp C1q est non-conjugé

Application

Veuillez nous consulter SVP
  • Specificité

    Complement C1 q antibody was raised against Human Complement C1 .

    Purification

    Affinity purified

    Pureté

    > 95 % pure

    Stérilité

    Filtered

    Immunogène

    Human Complement C1 q
    Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
  • Indications d'application

    Optimal conditions should be determined byt he investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Clear, colorless liquid, 0.2 µm filtered, containing 10 mM Sodium Phosphate, 0.15 M Sodium Chloride and 0.05 % (w/v) Sodium Azide. Protease/IgG free.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store at 2-8 °C.
  • Antigène

    C1q (Complement Fragment C1q (C1q))

    Autre désignation

    Complement C1q

    Sujet

    The C1q complex is potentially multivalent for attachment to the complement fixation sites of immunoglobulin. The sites are on the CH2 domain of IgG and, it is thought, on the CH4 domain of IgM. The appropriate peptide sequence of the complement fixing site might become exposed following complexing of the immunoglobulin, or the sites might always be available, but might require multiple attachment by C1q with critical geometry in order to achieve the necessary avidity.
Vous êtes ici:
Chat with us!